Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
ConditionHyperuricemia or Gout
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-65
SponsorOMNIFARMA LLC
About this trial
Multicentre, double-blind, randomized, placebo-controlled trial of the clinical efficacy of burdock root extract in patients with asymptomatic hyperuricemia, with the primary objective to assess the efficacy of the use of burdock root extract in patients with asymptomatic hyperuricaemia versus placebo
Eligibility criteria
Qualifiers
Hyperuricaemia confirmed by a laboratory, uric acid level from 360 to 540 μmol/L in women and from 420 to 540 μmol/L in men;
Age from 35 to 65 years at the baseline;
Patients examined by an experienced specialist not revealing any clinical evidences of gout or other somatic consequences of hyperuricaemia;
Not taking any other nutritional additives;
Disqualifiers
Age <35 or >65 years;
Fever (above 36.8 оС);
Pregnancy and lactation;
Patients with any somatic evidences of hyperuricaemia including gout taking antigout drugs during or within 6 months before the trial;
Trial design
Treatments tested in this trial
- Burdock ( Arctium lappa L.) root extract in a form of a nutritional additive
- Placebo
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov